Trader consensus on Polymarket reflects a 92.7% implied probability of no new coronavirus pandemic in 2026, anchored by CDC and WHO surveillance data showing no novel coronavirus—distinct from SARS-CoV-2—emerging with pandemic potential. As of mid-April 2026, COVID-19 remains endemic with low national wastewater levels (1.47 normalized for SARS-CoV-2), infections declining in 33 U.S. states per CDC Rt estimates, and global cases sparse per WHO dashboards, far below epidemic thresholds. Recent March variants like BA.3.2 ("Cicada") are SARS-CoV-2 descendants with immune escape traits but insufficient for WHO pandemic re-designation. Widespread population immunity from prior exposures further buffers risks. Realistic challenges include a zoonotic spillover of a highly transmissible novel strain prompting WHO Public Health Emergency declaration before year-end, though surveillance updates offer ongoing clarity.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoNuova pandemia di coronavirus nel 2026?
Nuova pandemia di coronavirus nel 2026?
The resolution source will be official announcements from the World Health Organization.
Mercato aperto: Jan 6, 2026, 2:40 PM ET
Resolver
0x65070BE91...The resolution source will be official announcements from the World Health Organization.
Resolver
0x65070BE91...Trader consensus on Polymarket reflects a 92.7% implied probability of no new coronavirus pandemic in 2026, anchored by CDC and WHO surveillance data showing no novel coronavirus—distinct from SARS-CoV-2—emerging with pandemic potential. As of mid-April 2026, COVID-19 remains endemic with low national wastewater levels (1.47 normalized for SARS-CoV-2), infections declining in 33 U.S. states per CDC Rt estimates, and global cases sparse per WHO dashboards, far below epidemic thresholds. Recent March variants like BA.3.2 ("Cicada") are SARS-CoV-2 descendants with immune escape traits but insufficient for WHO pandemic re-designation. Widespread population immunity from prior exposures further buffers risks. Realistic challenges include a zoonotic spillover of a highly transmissible novel strain prompting WHO Public Health Emergency declaration before year-end, though surveillance updates offer ongoing clarity.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti